KAIROS PHARMA, LTD. (KAPA) Operating income 2023–2025
KAIROS PHARMA, LTD. (KAPA) annual operating income history from SEC filings — each fiscal year as reported.
-$5.6MFY2025 · since FY2023: -$1.7M → -$5.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.6M | -137.8% |
| FY2024 | -$2.3M | -36.7% |
| FY2023 | -$1.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KAPA financial trends
KAPA RevenueKAPA Net incomeKAPA Net marginKAPA Gross profitKAPA Gross marginKAPA Operating marginKAPA Operating cash flowKAPA Free cash flowKAPA Capital expendituresKAPA Return on equityKAPA Stock buybacksKAPA Dividends paidKAPA Total assetsKAPA Total liabilitiesKAPA Shareholders’ equityKAPA overview →